Last reviewed · How we verify

T89 Low dose

Tasly Pharmaceuticals, Inc. · Phase 3 active Small molecule

T89 is a traditional Chinese medicine compound that improves myocardial energy metabolism and reduces ischemic injury in cardiovascular disease.

T89 is a traditional Chinese medicine compound that improves myocardial energy metabolism and reduces ischemic injury in cardiovascular disease. Used for Angina pectoris, Myocardial infarction, Heart failure.

At a glance

Generic nameT89 Low dose
Also known asDantonic®, Salvtonic®, Compound Danshen Dripping Pill
SponsorTasly Pharmaceuticals, Inc.
Drug classTraditional Chinese medicine compound
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

T89 (Danshen dripping pill) contains multiple active components that enhance ATP production in cardiac mitochondria, improve coronary blood flow, and reduce oxidative stress and apoptosis in ischemic myocardium. The formulation works through multiple pathways including mitochondrial protection, anti-inflammatory effects, and improvement of cardiac contractility.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results